BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 21666183)

  • 21. Progress in measles mortality reduction in Ethiopia, 2002-2009.
    Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closer to the goal: efforts in measles elimination in Germany 2010.
    Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
    J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of measles transmission in Brazil, 2000-2001.
    Prevots DR; Parise MS; Segatto TC; Siqueira MM; dos Santos ED; Ganter B; Perreira MC; Domingues CA; Lanzieri T; Da Silva JB
    J Infect Dis; 2003 May; 187 Suppl 1():S111-20. PubMed ID: 12721901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a measles elimination strategy on measles incidence in Malaysia.
    Saraswathy TS; Zahrin HN; Norhashmimi H; Az-Ulhusna A; Zainah S; Rohani J
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of supplementary immunization activities in measles-endemic areas: a case study from Guangxi, China.
    Zhuo J; Geng W; Hoekstra EJ; Zhong G; Liang X; Zhang J
    J Infect Dis; 2011 Jul; 204 Suppl 1():S455-62. PubMed ID: 21666199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(12):374-8. PubMed ID: 21451448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles surveillance.
    CDR (Lond Engl Wkly); 1991 Dec; 1(50):221. PubMed ID: 1669898
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles mortality reduction and pre-elimination in the African region, 2001-2009.
    Masresha BG; Fall A; Eshetu M; Sosler S; Alleman M; Goodson JL; Katsande R; Nshimirimana D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S198-204. PubMed ID: 21666162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surveillance of measles in Germany].
    Tischer A; Siedler A; Rasch G
    Gesundheitswesen; 2001 Nov; 63(11):703-9. PubMed ID: 11713702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh.
    Koehlmoos TP; Uddin J; Sarma H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S90-7. PubMed ID: 21666219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in global measles control, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N; Imnadze P; Baidoshvili L; Jabidze L; Tatishili N; Kurtsikashvili G; Lezhava T; Laurent E; Martin R
    Vaccine; 2010 Sep; 28(39):6455-62. PubMed ID: 20674880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.